肢端肥大症合并心脏损害1例并文献复习
摘要
肢端肥大症是垂体生长激素腺瘤在成年期的临床表现。该病起病隐匿,进展缓慢,初次就诊原因可以是其继发的其他系统器官病变,如高血压、糖尿病、睡眠呼吸暂停综合征等,接诊医生有意识关注患者体征及必要时完善垂体相关检查,才能避免漏诊及更全面评估患者病情。肢端肥大症目前的治疗方式是以手术治疗为主的综合治疗,其围术期治疗尤以心血管系统及呼吸系统为重。
出处
《现代医药卫生》
2016年第14期2270-2272,共3页
Journal of Modern Medicine & Health
参考文献16
-
1Melmed S. Acromegaly[J]. N Engl J Med, 1990,322 (14) : 966-977.
-
2Fazio S, Cittadini A, Biondi B, et al. Cardiovascular effects of short-term growth hormone hypersecretion[J]. J Clin Endocrinol Metab,2000,85 (1): 179-182.
-
3Legrand V, Beckers A, Pham VT,et al. Dramatic improvement of severe dilated cardiomyopathy in an acromegalic patient after treatment with octreo- tide and trans-sphenoidal surgery I J]. Eur Heart J, 1994,15 (9) : 1286-1289.
-
4Dutta P, Das S, Bhansali A, et al. Congestive heart failure in acromegaly : A review of 6 cases[J]. Indian J Endocrinol Metab, 2012,16 (6) :987-990.
-
5傅勇,王景全.肢端肥大症性心脏病[J].吉林医学,1993,14(2):65-66. 被引量:1
-
6杨萍.注射用醋酸奥曲肽微球[J].中国新药杂志,2005,14(10):1230-1231. 被引量:4
-
7Cozzi R, Attanasio R. Octreotide long-acting repeatable for acromegaly[J]. Expert Rev Clin Pharmacol, 2012,5 (2) : 125-143.
-
8Maison P,Tropeano AI,Macquin-Mavier I,et al. Impact of somatostatin analogson the heart in acromegaly:a metaanalysis[J]. J Clin Endocrinol Metab, 2007,92(5) : 1743-1747.
-
9Colao A, Marzullo P, Cuocolo A, et al. Reversal of acromegalic cardiomyo- pathy in young but not in middle-aged patients after 12 months of treat- ment with the depot long-acting somatostatin analogue octreotide[J]. Clin Endocrinol (Oxf) ,2003,58 (2) : 169-176.
-
10Jayasena CN, Comninos AN, Clarke H, et al. The effects of long-term growth hormone and insulin-like gro~h factor-1 exposure on the develop- ment of cardiovascular,cerebrovascular and metabolic co-morbidities in treated patients with acromegaly[J]. Clin Endocrinol (Oxf), 2011,75 (2): 220-225.
二级参考文献13
-
1毛志钢,王海军,何东升,徐伟光,冯雷.影响垂体生长激素腺瘤经蝶手术疗效的因素分析[J].中国微侵袭神经外科杂志,2006,11(4):151-153. 被引量:7
-
2Melmed S, Casanueva FF, Cavagnini AF, et al. Guidelines for acromegaly management [J]. J Clin Endocrinol Metab,2002; 87(9):.4054-4058.
-
3Bevan JS, Atkin SL, Atkinson AB. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I,and tumor size [J]. J Clin Endocrinol Metab, 2002; 87(10):4554-4563.
-
4Trainer P, Drake WM, Katznelson L, et al. Treatment of acromegaly with growth hormone receptor antagonist pegvisomant [J]. N Engl J Med, 2000; 342(16): 1171-1177.
-
5Ben-shlomo A, Melmed S. Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly [J]. J Clin Endocrinol Metab, 2003; 88(3):963-968.
-
6Ghosh AK. Factors involved in the regulation of type I collagen gene expression: implication in fibrosis [J]. Exp Biol Med (Maywood), 2002; 227(5): 301-314.
-
7Naganuma H, Satoh E, Nukui H. Technical consideration of transsphenoidal removal of fibrous pituitary adenomas and evaluation of collagen content and subtype in the adenomas[J]. Neurol Med Chir (Tokyo), 2002; 42(5): 202-213.
-
8Schuppan D, Koda M, Bauer M, et al. Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets[J]? Acta Gastroenterol Belg, 2000; 63(4): 366-370.
-
9Gore-Hyer E, Shegogue D, Markiewicz M, et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells [J]. Am J Physiol Renal Physiol, 2002;283(4): 707-716.
-
10Crean JK, Finlay D, Murphy M, et al. The role of p42/44MAPK and protein kinase B in connective tissue growthfactor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human messagial cells [J]. J Biol Chern, 2002; 277(46): 44187-44194.
共引文献6
-
1孟庆虎,于春江.垂体生长激素腺瘤药物治疗进展[J].中华神经外科杂志,2009,25(4):381-383. 被引量:1
-
2王玲丽,张瑜,郭燕.肌肉注射醋酸奥曲肽微球的护理体会[J].全科护理,2012,10(20):1849-1850. 被引量:2
-
3雷霓,肖伟伟,毛志钢,蒋小兵,朱永红.新颖海洋化合物SZ-685C抑制GH3细胞增殖并诱导其凋亡[J].中华显微外科杂志,2012,35(5):356-359.
-
4曹磊,张亚卓.生长激素型垂体腺瘤的药物治疗现状[J].中华神经外科杂志,2013,29(10):1076-1078. 被引量:3
-
5梁苑英竹,林晓鸣,刘万卉,庾莉菊,杨化新.肽类微球注射剂释放度实验评价研究进展[J].中国新药杂志,2017,26(24):2918-2923. 被引量:7
-
6李际敏,谢翠华,罗祥蓉,蒋娅,周琳,曹瑛,张倩,孟敏.长效奥曲肽治疗生长激素型垂体腺瘤的注射操作[J].分子影像学杂志,2018,41(4):569-572.
-
1马驰原,史继新,王汉东,杭春华,成惠林,潘云曦,谢韡,孙康建,樊友武,李杰,李劲松.并发心血管病变的肢端肥大症的围手术期治疗[J].中华外科杂志,2005,43(17):1157-1157. 被引量:1
-
2杨义,任祖渊,苏长保,王任直,马文斌.垂体生长激素腺瘤合并睡眠呼吸暂停综合征的治疗[J].中华神经外科杂志,2001,17(5):326-327. 被引量:3
-
3马明德,丁慧君,张红,桑沛霞.肺癌并糖尿病围术期治疗23例分析[J].中国误诊学杂志,2002,2(11):1725-1726. 被引量:5
-
4黄玉林.妇科疾病合并糖尿病围术期浅析[J].基层医学论坛,2010,14(20):581-582. 被引量:1
-
5马秉灵,刘晓恩,张沛刚,贺丕瑞,刘凯.先天性心脏病并肺动脉高压围术期治疗[J].中国现代医生,2008,46(5):53-53. 被引量:5
-
6邢青梅,刘宽荣,蔡丽平.子宫颈癌合并缺血性心脏病围术期治疗[J].当代医学,2012,18(11):106-107. 被引量:2
-
7邢素平,刘宽荣,马聪平.子宫肌瘤合并缺血性心脏病围术期治疗[J].中国实用医刊,2012,39(17):115-115. 被引量:3
-
8刘伦翠,卢林,高俊英,许秀萍.原发性胆汁性肝硬化22例误诊分析[J].新医学,2008,39(10):677-678. 被引量:2
-
9高洪法,于念之.急性腹痛的鉴别[J].基层医学论坛,2004,8(6):570-571. 被引量:1
-
10陈鲁原.心衰、心绞痛的鉴别诊断[J].中国全科医学(医生读者版),2010(1):14-15.